Among them, thioredoxin domain-containing protein 5 (TXNDC5) is reportedly involved in several malignancies, including cervical cancer, prostate cancer, and hepatocellular carcinoma [18–20]. This evidence concerns the gene TXNDC5 and prostate cancer.